Tag Archives: The Stem Cell Blog

Global Synthetic Biology Market – Industry Analysis, Size, Trends, Growth, Share and Forecast 2018 – 2023 – Technical Progress

Continue reading

2018-05-07 NEWS

Global Synthetic Biology Market – Industry Analysis, Size, Trends, Growth, Share and Forecast 2018 – 2023
Technical Progress
A new research report by Marketdesk.us titled ‘Global Synthetic Biology Market’: Global Industry Analysis (2012-2018) and Opportunity Assessment (2018-2023)’ gives a comprehensive way to deal with the worldwide Synthetic Biology advertise with the

and more »

Continue reading

2018-05-07 NEWS

Global Synthetic Biology Market – Industry Analysis, Size, Trends, Growth, Share and Forecast 2018 – 2023
Technical Progress
A new research report by Marketdesk.us titled ‘Global Synthetic Biology Market’: Global Industry Analysis (2012-2018) and Opportunity Assessment (2018-2023)’ gives a comprehensive way to deal with the worldwide Synthetic Biology advertise with the

and more »

Continue reading

2018-05-07 NEWS

Investor’s Business Daily

First US drug priced at more than $1 million may be on the horizon
CNBC
New gene therapies that aim to cure hemophilia, a disease affecting the blood’s ability to clot, may carry prices of $1.5 million or more, analysts at Leerink wrote …
Hemophilia Gene TherapiesInvestor’s Business Daily

all 3 news articles »

Continue reading

2018-05-07 NEWS

CBC.ca

More than 400 people register to help Alberta man find stem cell donor
CBC.ca
Nguyen’s family organized Sunday’s event to raise awareness of the lack of stem cell donors for ethnic minorities, particularly for people of Asian descent. His sister Susan Nguyen said they never expected more than 400 people would register as donors
Huge turnout at drive for diverse stemcell donors gives hope to family of Bille NguyenToronto Star

all 2 news articles »

Continue reading

2018-05-07 NEWS

Genetic Engineering & Biotechnology News

25 Up and Coming Gene Therapies
Genetic Engineering & Biotechnology News
Additional figures furnished to GEN by Informa show the extent of genetherapy development: Informa Pharma Intelligence’s Trialtrove database records 729 gene therapies as having been developed, of which nearly two-thirds (461) were preclinical. Those